NM_005629.4:c.1146G>A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2

The NM_005629.4(SLC6A8):​c.1146G>A​(p.Pro382Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000363 in 1,045,851 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. P382P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 24)
Exomes 𝑓: 0.000036 ( 0 hom. 14 hem. )

Consequence

SLC6A8
NM_005629.4 synonymous

Scores

1
8

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -5.20

Publications

0 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.19111669).
BP6
Variant X-153693909-G-A is Benign according to our data. Variant chrX-153693909-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 465140.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-5.2 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1146G>A p.Pro382Pro synonymous_variant Exon 8 of 13 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1116G>A p.Pro372Pro synonymous_variant Exon 8 of 13 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.801G>A p.Pro267Pro synonymous_variant Exon 8 of 13 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1146G>A p.Pro382Pro synonymous_variant Exon 8 of 13 1 NM_005629.4 ENSP00000253122.5 P48029-1

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD2 exomes
AF:
0.0000434
AC:
5
AN:
115313
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000363
AC:
38
AN:
1045851
Hom.:
0
Cov.:
31
AF XY:
0.0000415
AC XY:
14
AN XY:
337635
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24861
American (AMR)
AF:
0.000178
AC:
5
AN:
28051
Ashkenazi Jewish (ASJ)
AF:
0.0000538
AC:
1
AN:
18594
East Asian (EAS)
AF:
0.0000366
AC:
1
AN:
27314
South Asian (SAS)
AF:
0.000181
AC:
9
AN:
49760
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37095
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2862
European-Non Finnish (NFE)
AF:
0.0000271
AC:
22
AN:
813265
Other (OTH)
AF:
0.00
AC:
0
AN:
44049
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
24
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000101
AC:
1

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Creatine transporter deficiency Benign:1
Nov 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.5
DANN
Benign
0.82
FATHMM_MKL
Benign
0.18
N
MetaRNN
Benign
0.19
T
MetaSVM
Benign
-0.91
T
PhyloP100
-5.2
PROVEAN
Pathogenic
-8.0
D
REVEL
Benign
0.053
MutPred
0.24
Gain of methylation at G44 (P = 0.009);
MVP
0.50
ClinPred
0.72
D
GERP RS
-9.7
PromoterAI
0.059
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782627741; hg19: chrX-152959364; API